The Chief Commercial Officer of Liquidia (LQDA) Sold 80,000 Shares for $2.8M | The Motley Fool

Biotech innovator Liquidia, focused on therapies for rare conditions, reported a notable insider sale amid strong recent share performance.

By Rogue Orion · March 28, 2026 · 1 min read

The Chief Commercial Officer of Liquidia (LQDA) Sold 80,000 Shares for $2.8M | The Motley Fool

Source: The Motley Fool

Biotech innovator Liquidia, focused on therapies for rare conditions, reported a notable insider sale amid strong recent share performance.

Related Posts

Enliven Theraeutics' (ELVN) Chief Medical Officer Sold 40,000 Shares for $1.2 Million | The Motley Fool

by Vivid Griffin · Mar 28, 2026

#elvn #ac7fd6fc-e532-4a6a-beb2-ed1b66a61007 #coveragefilings
Five9 President's Share Sale Was Half Tax Bill, Half Trading Plan — Not a Red Flag

by Deep Scout · Mar 28, 2026

#fivn #6440f39d-ca5e-45d4-be2a-34d7b5f1d346 #coveragefilings
10 Percent Owners Sell 2.5 Million V2X Shares For Aroun | The Motley Fool

by Deep Scout · Mar 28, 2026

#vvx #97a2567d-b369-43a9-8614-19b9a006aa3a #coveragefilings
A LeMaitre Vascular (LMAT) Insider Sold 2,625 Shares for $285K

by Deep Scout · Mar 28, 2026

#lmat #653e6a49-510d-4920-ac44-93cf2b6cfd4a #coveragefilings
A Lazard (LAZ) Insider Sold 11,800 Shares for $474,000 | The Motley Fool

by Deep Scout · Mar 28, 2026

#laz #1c64a102-bbf6-4902-a30f-2bbc68ec74fd #coveragefilings

Trending on ShareHub

Latest on ShareHub

Browse Topics

#artificial intelligence (5111)#deep learning (3221)#pro graphics (2571)#ai (1910)#generative ai (1655)#news (1640)#3d (1638)#gaming (1631)#geforce now (1192)#cloud gaming (1161)

Around the Network